NKARTA INC (NKTX) Fundamental Analysis & Valuation

NASDAQ:NKTX • US65487U1088

Current stock price

2.17 USD
-0.17 (-7.26%)
At close:
2.21 USD
+0.04 (+1.84%)
After Hours:

This NKTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NKTX Profitability Analysis

1.1 Basic Checks

  • NKTX had negative earnings in the past year.
  • NKTX had a negative operating cash flow in the past year.
  • NKTX had negative earnings in each of the past 5 years.
  • In the past 5 years NKTX always reported negative operating cash flow.
NKTX Yearly Net Income VS EBIT VS OCF VS FCFNKTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • NKTX has a better Return On Assets (-25.75%) than 70.41% of its industry peers.
  • NKTX has a Return On Equity of -33.33%. This is in the better half of the industry: NKTX outperforms 73.31% of its industry peers.
Industry RankSector Rank
ROA -25.75%
ROE -33.33%
ROIC N/A
ROA(3y)-25.65%
ROA(5y)-27.09%
ROE(3y)-33.49%
ROE(5y)-32.64%
ROIC(3y)N/A
ROIC(5y)N/A
NKTX Yearly ROA, ROE, ROICNKTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NKTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NKTX Yearly Profit, Operating, Gross MarginsNKTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NKTX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, NKTX has more shares outstanding
  • The number of shares outstanding for NKTX has been increased compared to 5 years ago.
  • There is no outstanding debt for NKTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NKTX Yearly Shares OutstandingNKTX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
NKTX Yearly Total Debt VS Total AssetsNKTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -1.38, we must say that NKTX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -1.38, NKTX perfoms like the industry average, outperforming 52.03% of the companies in the same industry.
  • NKTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.38
ROIC/WACCN/A
WACCN/A
NKTX Yearly LT Debt VS Equity VS FCFNKTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • NKTX has a Current Ratio of 12.69. This indicates that NKTX is financially healthy and has no problem in meeting its short term obligations.
  • NKTX's Current ratio of 12.69 is amongst the best of the industry. NKTX outperforms 86.65% of its industry peers.
  • NKTX has a Quick Ratio of 12.69. This indicates that NKTX is financially healthy and has no problem in meeting its short term obligations.
  • NKTX's Quick ratio of 12.69 is amongst the best of the industry. NKTX outperforms 86.65% of its industry peers.
Industry RankSector Rank
Current Ratio 12.69
Quick Ratio 12.69
NKTX Yearly Current Assets VS Current LiabilitesNKTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. NKTX Growth Analysis

3.1 Past

  • NKTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.66%, which is quite good.
EPS 1Y (TTM)15.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, NKTX will show a small growth in Earnings Per Share. The EPS will grow by 5.63% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y2.61%
EPS Next 2Y11.72%
EPS Next 3Y-4.14%
EPS Next 5Y5.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NKTX Yearly Revenue VS EstimatesNKTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
NKTX Yearly EPS VS EstimatesNKTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. NKTX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NKTX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NKTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NKTX Price Earnings VS Forward Price EarningsNKTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NKTX Per share dataNKTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • NKTX's earnings are expected to decrease with -4.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.72%
EPS Next 3Y-4.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NKTX Dividend Analysis

5.1 Amount

  • NKTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NKTX Fundamentals: All Metrics, Ratios and Statistics

NKARTA INC

NASDAQ:NKTX (4/10/2026, 8:00:01 PM)

After market: 2.21 +0.04 (+1.84%)

2.17

-0.17 (-7.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-25
Earnings (Next)05-07
Inst Owners77.93%
Inst Owner Change0%
Ins Owners0.47%
Ins Owner Change5.07%
Market Cap154.70M
Revenue(TTM)N/A
Net Income(TTM)-104.08M
Analysts85
Price Target12.24 (464.06%)
Short Float %8.22%
Short Ratio7.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.41%
Min EPS beat(2)-14.07%
Max EPS beat(2)9.26%
EPS beat(4)3
Avg EPS beat(4)3.44%
Min EPS beat(4)-14.07%
Max EPS beat(4)14.39%
EPS beat(8)5
Avg EPS beat(8)6.25%
EPS beat(12)9
Avg EPS beat(12)8.72%
EPS beat(16)10
Avg EPS beat(16)6.24%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-6.59%
EPS NQ rev (3m)-8.7%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-1.4
EYN/A
EPS(NY)-1.36
Fwd EYN/A
FCF(TTM)-1.47
FCFYN/A
OCF(TTM)-1.4
OCFYN/A
SpS0
BVpS4.4
TBVpS4.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.75%
ROE -33.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-25.65%
ROA(5y)-27.09%
ROE(3y)-33.49%
ROE(5y)-32.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.18%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.69
Quick Ratio 12.69
Altman-Z -1.38
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)770.74%
Cap/Depr(5y)709.73%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.71%
EPS Next Y2.61%
EPS Next 2Y11.72%
EPS Next 3Y-4.14%
EPS Next 5Y5.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.72%
EBIT Next 3Y4.08%
EBIT Next 5Y2.85%
FCF growth 1Y8.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.71%
OCF growth 3YN/A
OCF growth 5YN/A

NKARTA INC / NKTX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NKARTA INC (NKTX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NKTX.


What is the valuation status of NKARTA INC (NKTX) stock?

ChartMill assigns a valuation rating of 0 / 10 to NKARTA INC (NKTX). This can be considered as Overvalued.


Can you provide the profitability details for NKARTA INC?

NKARTA INC (NKTX) has a profitability rating of 1 / 10.


What is the financial health of NKARTA INC (NKTX) stock?

The financial health rating of NKARTA INC (NKTX) is 7 / 10.